CORC

浏览/检索结果: 共6条,第1-6条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Rational Design, synthesis and biological evaluation of novel triazole derivatives as potent and selective PRMT5 inhibitors with antitumor activity 期刊论文
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2019, 卷号: 33, 期号: 8, 页码: 775-785
作者:  Zhu, Kongkai;  Shao, Jingwei;  Tao, Hongrui;  Yan, Xue;  Luo, Cheng
收藏  |  浏览/下载:12/0  |  提交时间:2020/07/01
Design and Synthesis of Potent, Selective Inhibitors of Protein Arginine Methyltransferase 4 against Acute Myeloid Leukemia 期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 卷号: 62, 期号: 11, 页码: 5414-5433
作者:  Guo, Zuhao;  Zhang, Zhuqing;  Yang, Hong;  Cao, Danyan;  Xu, Xiaowei
收藏  |  浏览/下载:16/0  |  提交时间:2020/07/01
Discovery of Novel PRMT5 Inhibitors by Virtual Screening and Biological Evaluations 期刊论文
CHEMICAL & PHARMACEUTICAL BULLETIN, 2019, 卷号: 67, 期号: 4, 页码: 382-388
作者:  Tao, Hongrui;  Yan, Xue;  Zhu, Kongkai;  Zhang, Hua
收藏  |  浏览/下载:14/0  |  提交时间:2020/07/01
A patent review of arginine methyltransferase inhibitors (2010-2018) 期刊论文
EXPERT OPINION ON THERAPEUTIC PATENTS, 2019, 卷号: 29, 期号: 2, 页码: 97-114
作者:  Li, Xiao;  Wang, Chen;  Jiang, Hao;  Luo, Cheng
收藏  |  浏览/下载:8/0  |  提交时间:2020/07/01
The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLAR(L) in human lung cancer cells 期刊论文
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 卷号: 38, 期号: 1
作者:  Li, Mingyue;  An, Wentao;  Xu, Linyan;  Lin, Yidan;  Su, Ling
收藏  |  浏览/下载:31/0  |  提交时间:2019/12/11
CFLAR  PRMT1  PRMT5  ITCH  Apoptosis  
Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4 alpha 期刊论文
THERANOSTICS, 2019, 卷号: 9, 期号: 9, 页码: 2606-2617
作者:  Zheng, Bai-Nan;  Ding, Chen-Hong;  Chen, Shi-Jie;  Zhu, Kongkai;  Shao, Jingwei
收藏  |  浏览/下载:10/0  |  提交时间:2020/07/01


©版权所有 ©2017 CSpace - Powered by CSpace